Results 41 to 50 of about 3,205,664 (326)

Medical Ethics. [PDF]

open access: yesJAMA: The Journal of the American Medical Association, 1897
n ...
openaire   +2 more sources

The relationship between medical law and good medical ethics [PDF]

open access: yes, 2014
In the UK, medical ethics and law are often thought of and taught together, but while ‘good medical ethics’ is often reflected in law–the need to obtain a patient's adequately informed consent, for example—this is not necessarily the case.
Jackson, Emily
core   +1 more source

Escape from TGF‐β‐induced senescence promotes aggressive hallmarks in epithelial hepatocellular carcinoma cells

open access: yesMolecular Oncology, EarlyView.
Chronic TGF‐β exposure drives epithelial HCC cells from a senescent state to a TGF‐β resistant mesenchymal phenotype. This transition is characterized by the loss of Smad3‐mediated signaling, escape from senescence, enhanced invasiveness and metastatic potential, and upregulation of key resistance modulators such as MARK1 and GRM8, ultimately promoting
Minenur Kalyoncu   +11 more
wiley   +1 more source

Practicing Sport in the Age Group 21-34 and the Risk of Breast Cancer - Analysis of the Results of a Retrospective Study

open access: yesCentral European Journal of Sport Sciences and Medicine, 2023
Breast cancer is the most common malignant tumor in women, so it is important to study the factors that can protect against it. One of them is physical activity, which has become the area of our interest, especially the practice of sports by women aged ...
Aleksandra Kładna   +5 more
doaj   +1 more source

Multi‐omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine

open access: yesMolecular Oncology, EarlyView.
This study highlights the importance of multi‐omic analyses in characterizing colorectal cancers. Indeed, our analysis revealed a rare CMS1 exhibiting dampened immune activation, including reduced PD‐1 expression, moderate CD8+ T‐cell infiltration, and suppressed JAK/STAT pathway.
Livia Concetti   +10 more
wiley   +1 more source

Practice of code of ethics and associated factors among medical doctors in Addis Ababa, Ethiopia. [PDF]

open access: yesPLoS ONE, 2018
INTRODUCTION:In the health sector, questions are being raised about the possible threats to the accepted principles of ethics such as autonomy, beneficence, non malfeasance and justice in the delivery of health care.
Mesafint Abeje Tiruneh   +1 more
doaj   +1 more source

Medical Ethics as Professional Ethics [PDF]

open access: yesThe Korean Journal of Gastroenterology, 2012
Contemporary medical ethics is far from the traditional concept of "In-Sul (benevolent art)" or "Yul-Li (倫, ethics), which emphasizes so much the personality or the character of a doctor. Nowadays, medical ethics should be considered as "professional ethics" which regulates the acts and medical practices of ordinary doctors in their daily practice. The
openaire   +3 more sources

Patient Suffering and the Anointing of the Sick [PDF]

open access: yes, 1992
Anthologized in On Moral Medicine: Theological Perspectives in Medical Ethics, 2nd edition. Edited by Stephen E. Lammers and Allen Verhey. Grand Rapids: Eerdmans, 1998, 356-364. And in On Moral Medicine: Theological Perspectives in Medical Ethics, 3rd
Lysaught, M. Therese
core   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy